RPL35A and cholangiocarcinoma: This study not only clarified the role of RPL35A in the progression of CCA, but also preliminarily explored the molecular mechanism of RPL35A promoting CCA, suggesting that RPL35A might be a new potential therapeutic target for CCA, which was helpful for the development of new therapeutic strategies.